Variation in the inhibition of restriction enzyme cleavage of lambda phage DNA produced by two covalent binding antitumor agents: anthramycin and mitomycin C.
D000876:Anthramycin / Q000494:pharmacology*; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D010582:Bacteriophage lambda / Q000235:genetics*; D001570:Benzodiazepinones / Q000494:pharmacology*; D055598:Chemical Phenomena; D002621:Chemistry; D004262:DNA Restriction Enzymes / Q000037:antagonists & inhibitors*; D004279:DNA, Viral / Q000235:genetics*; D007700:Kinetics; D016685:Mitomycin; D008937:Mitomycins / Q000494:pharmacology*
D000903:Antibiotics, Antineoplastic; D001570:Benzodiazepinones; D004279:DNA, Viral; D008937:Mitomycins; D000876:Anthramycin; D016685:Mitomycin; D004262:DNA Restriction Enzymes